Azeem Latib
Latest contributions
The continuum of valvular heart disease: a lifetime management approach
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...
Innovation in transcatheter mitral valve interventions
21 May 2026 – From EuroPCR 2026
This comprehensive session presents the latest innovations in transcatheter mitral valve interventions, highlighting cutting-edge devices and clinical experiences. Topics include early feasibility studies of novel hemivalve systems, first-in-human experiences with new mitral valve replacement technologies, advances in transcatheter edge-to-edge repair (TEER) with one-year outcome data, and...
Spectrum of cardiogenic shock
21 May 2026 – From EuroPCR 2026
This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.
MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience
20 May 2026 – From EuroPCR 2026
This session examines the clinical evidence and experiential insights regarding the MagicTouch sirolimus-coated balloon (SCB) for treating coronary and peripheral artery disease. It reviews long-term comparative data versus paclitaxel-coated balloons, application techniques, integration into current practices, and findings from major trials such as SIRONA and SIMPLE-DM,...
DK Score Pro in focus: innovation, evidence, and everyday practice
20 May 2026 – From EuroPCR 2026
Watch this EuroPCR 2026 session to better understand how lesion preparation strategies can be optimised in complex PCI using directional scoring balloon technology with DK Score Pro.
Clinical evidence is reviewed, including insights from the SCORE CHINA registry, alongside practical considerations for integrating this approach into routine...
TAVI in aortic regurgitation with a dedicated valve - LIVE case
20 May 2026 – From EuroPCR 2026
An 80-year-old male with chronic kidney disease, a history of colon cancer (2013), paroxysmal AF, and LAD PCI 2 weeks earlier presented with symptomatic severe type III AR. He had normal LV function, but early LV dilation. The mechanism of AR was a combination of primary...
Coronary innovations and artificial intelligence: new devices, smarter tools, better outcomes
20 May 2026 – From EuroPCR 2026
This session provides a practical update on emerging coronary innovations and AI technologies, including next-generation calcium modification devices, bioresorbable scaffolds, sirolimus drug-coated balloons, and AI-driven coronary physiology and imaging tools. It offers a roadmap for integrating these advancements into clinical practice, addressing technology selection, reimbursement, training,...
Disrupting the aorta and valves: the next transcatheter wave
18 May 2026 – From EuroPCR 2026
Delve into the next wave of transcatheter interventions disrupting the aorta and valves. This session covers pioneering minimally invasive ascending aortic repair, novel polymeric aortic valve implants, and innovative devices for tricuspid repair and leaflet replacement.
Rapid fire session on next generation structural heart and valve therapies
18 May 2026 – From EuroPCR 2026
An intensive rapid-fire session presenting the latest advancements in next-generation structural heart and valve therapies, including novel transcatheter systems for aortic and mitral valve repair, innovative solutions for tricuspid regurgitation, and implant-free PFO closure technologies.
In what situation is emergency transcatheter valve intervention a valid alternative to surgery?
16 Nov 2025 – From PCR London Valves 2025
Azeem Latib and Giuseppe Tarantini discuss how transcatheter therapies are increasingly used to treat critically ill patients with severe valvular disease and cardiogenic shock—patients once considered untreatable. They highlight cases ranging from severe AS with ACS to acute papillary muscle rupture and acute severe regurgitation, showing...
Cardiovalve hits the TARGET: advancing transcatheter valve replacement
18 Nov 2025 – From PCR London Valves 2025
This session highlights the features and procedural steps of the next-generation Cardiovalve systems for tricuspid and mitral valve replacement. It reviews interim results from the TARGET study, emphasizing echocardiographic findings and reverse remodeling effects, and discusses best practices for patient selection and the learning pathway to...
Paravalvular leaks and VSD percutaneous closure - Recorded cases
17 Nov 2025 – From PCR London Valves 2025
Recorded case 1: A 56-year-old female with a prior mechanical mitral valve replacement (Star GK, 2018), permanent AF, and normal LV function presented with recurrent HF admissions due to paravalvular leaks. She was treated with implantation of multiple plugs via a transseptal approach using a Destination...
Tricuspid repair or replacement - Matching the patient to the procedural strategy
17 Nov 2025 – From PCR London Valves 2025
This session addresses the nuanced decision-making process in selecting appropriate transcatheter tricuspid repair or replacement strategies. It covers the current device landscape, patient selection criteria based on anatomical and clinical factors, and discusses emerging challenges such as pacing lead management, anticoagulation, and outcome definitions.
Mitral TEER - LIVE Case
16 Nov 2025 – From PCR London Valves 2025
Watch this live case followed by a recorded case, regarding a 75-year-old male with type 2 DM, permanent AF, and severe LV dysfunction (30%), with a history of RCA PCI one month earlier and three hospitalizations for heart failure, presented with severe secondary mitral and tricuspid...
Rapid fire on ortothopic TTVR
16 Nov 2025 – From PCR London Valves 2025
This rapid-fire session presents an overview of the latest orthotopic transcatheter tricuspid valve replacement (TTVR) devices. It features concise discussions on multiple innovative systems including Evoque, Laplace, VDyne, Topaz, and Cardiovalve, offering insights into their design characteristics and clinical applications in tricuspid valve disease management.
Emergency transcatheter valve interventions: alternative therapy or bridge to surgery?
16 Nov 2025 – From PCR London Valves 2025
This session offers a compelling case-based exploration of emergency transcatheter valve interventions, demonstrating their potential as life-saving alternatives or bridges to surgery in high-risk patients. Through detailed clinical scenarios including cardiogenic shock, acute papillary muscle rupture, and severe aortic regurgitation from infective endocarditis, participants gain practical...
EuroPCR 2025: innovation, clinical trials and education
11 Jun 2025
Discover what D. Milasinovic and A. Latib shared on the takeaways of EuroPCR 2025.
TAVI for bioprosthetic valve failure - LIVE Case
22 May 2025 – From EuroPCR 2025
A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...
New devices for structural interventions
21 May 2025 – From EuroPCR 2025
Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
Mitral hotline: new devices
20 May 2025 – From EuroPCR 2025
Stay updated on emerging devices in mitral valve repair and replacement with this session covering novel technologies including transcatheter edge-to-edge repair (TEER), posterior leaflet restoration, transfemoral mitral annuloplasty, and a first-in-human transseptal TMVR system. Clinical trial data and early feasibility experiences provide valuable insights into advancing...
Degeneration of TAVI valves: a new target for innovations
19 May 2025 – From EuroPCR 2025
Discover the latest innovations targeting degeneration of TAVI valves, including expert presentations and cutting-edge technologies like The Splitter, an enabler for transcatheter aortic valve-in-valve implantation.
The Jon DeHaan Foundation Award competition
19 May 2025 – From EuroPCR 2025
Witness innovation in action at the Jon DeHaan Foundation Award competition featuring groundbreaking technologies like synchronized diaphragmatic stimulation for heart failure and novel devices for aortic bioprosthesis and interatrial shunting.
What is new in atrioventricular valves?
19 May 2025 – From EuroPCR 2025
Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.
Heart to Heart Conversations podcasts – expert insights in interventional cardiology, anytime, anywhere
06 Feb 2025
Stay ahead in interventional cardiology with Heart-to-heart podcasts, the audio companion to our acclaimed webinar series.
Focus on Innovation - PCR London Valves 2024
Azeem Latib and Jose Calle Gordo reflect on the PCR London Valves 2024 programme, which showcased groundbreaking advancements in valve technology. Highlights included sessions on transforming ideas into market-ready devices, intimate small-group discussions fostering meaningful exchange, and a hands-on innovation session to explore new devices. The...
Best of science and education in cardiovascular interventional medicine in 2024
16 Dec 2024
Dear Colleagues, dear PCR Companions,
As we welcome a new year, it is the perfect time to reflect on what we achieved together over the past year—both as a celebration of our successes and as motivation to continue improving in the year ahead.
2024 was a record year...
What is the future role of 3D ICE in tricuspid valve intervention?
26 Nov 2024 – From PCR London Valves 2024
Discover insights on imaging in tricuspid valve management in this engaging PCR London Valves 2024 roundtable discussion with Jennifer Franke, Felix Kreidel, and Azeem Latib.
Explore the potential of 3D intracardiac echocardiography as a cutting-edge tool for advanced imaging, set to transform clinical practice as it adoption...
Parading progress in transcatheter valve interventions
25 Nov 2024 – From PCR London Valves 2024
Curious about the future of transcatheter valve interventions? Watch this video to get an exclusive preview of groundbreaking (pre-CE mark) technologies shaping the future of valve repair!
You’ll discover the latest innovations in structural intervention devices, including next-gen technologies like the Mitral Butterfly, Vesalius, MonarQ and Luna...
Transcatheter mitral valve replacement - Are we there yet?
25 Nov 2024 – From PCR London Valves 2024
Are we ready to embrace transcatheter mitral valve replacement (TMVR) as the next big step in mitral interventions? Find out in this must-watch video!
Discover the key anatomical factors that favor TMVR over TEER, get acquainted with cutting-edge TMVR platforms like Tioga, Cephea and Intrepid, and master...
